Literature DB >> 24385505

Cardiac stem cell biology: glimpse of the past, present, and future.

Elena Matsa1, Karim Sallam, Joseph C Wu.   

Abstract

Cardiac regeneration strategies and de novo generation of cardiomyocytes have long been significant areas of research interest in cardiovascular medicine. In this review, we outline a variety of common cell sources and methods used to regenerate cardiomyocytes and highlight the important role that key Circulation Research articles have played in this flourishing field.

Entities:  

Keywords:  adult stem cells; embryonic stem cells; induced pluripotent stem cells

Mesh:

Year:  2014        PMID: 24385505      PMCID: PMC6430634          DOI: 10.1161/CIRCRESAHA.113.302895

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  23 in total

1.  Comparison of Non-Coding RNAs in Exosomes and Functional Efficacy of Human Embryonic Stem Cell- versus Induced Pluripotent Stem Cell-Derived Cardiomyocytes.

Authors:  Won Hee Lee; Wen-Yi Chen; Ning-Yi Shao; Dan Xiao; Xulei Qin; Natalie Baker; Hye Ryeong Bae; Tzu-Tang Wei; Yongjun Wang; Praveen Shukla; Haodi Wu; Kazuki Kodo; Sang-Ging Ong; Joseph C Wu
Journal:  Stem Cells       Date:  2017-07-31       Impact factor: 6.277

Review 2.  The extracellular matrix in myocardial injury, repair, and remodeling.

Authors:  Nikolaos G Frangogiannis
Journal:  J Clin Invest       Date:  2017-05-01       Impact factor: 14.808

Review 3.  The role of transforming growth factor (TGF)-β in the infarcted myocardium.

Authors:  Nikolaos G Frangogiannis
Journal:  J Thorac Dis       Date:  2017-03       Impact factor: 2.895

4.  Human Engineered Heart Muscles Engraft and Survive Long Term in a Rodent Myocardial Infarction Model.

Authors:  Johannes Riegler; Malte Tiburcy; Antje Ebert; Evangeline Tzatzalos; Uwe Raaz; Oscar J Abilez; Qi Shen; Nigel G Kooreman; Evgenios Neofytou; Vincent C Chen; Mouer Wang; Tim Meyer; Philip S Tsao; Andrew J Connolly; Larry A Couture; Joseph D Gold; Wolfram H Zimmermann; Joseph C Wu
Journal:  Circ Res       Date:  2015-08-19       Impact factor: 17.367

Review 5.  Current Status and Perspectives in Stem Cell Therapy for Heart.

Authors:  Fen-Chiung Lin; Wen-Pin Chen; Pao-Hsien Chu; Kou-Gi Shyu; Ming-Shien Wen
Journal:  Acta Cardiol Sin       Date:  2014-09       Impact factor: 2.672

Review 6.  Induced pluripotent stem cells for cardiovascular disease: from product-focused disease modeling to process-focused disease discovery.

Authors:  Katherine A Campbell; Andre Terzic; Timothy J Nelson
Journal:  Regen Med       Date:  2015-10-06       Impact factor: 3.806

Review 7.  Translation of Human-Induced Pluripotent Stem Cells: From Clinical Trial in a Dish to Precision Medicine.

Authors:  Nazish Sayed; Chun Liu; Joseph C Wu
Journal:  J Am Coll Cardiol       Date:  2016-05-10       Impact factor: 24.094

8.  Patient-Specific Pluripotent Stem Cells in Doxorubicin Cardiotoxicity: A New Window Into Personalized Medicine.

Authors:  Daniel Bernstein; Paul Burridge
Journal:  Prog Pediatr Cardiol       Date:  2014-12-01

9.  REVIVE Trial: Retrograde Delivery of Autologous Bone Marrow in Patients With Heart Failure.

Authors:  Amit N Patel; Sanjay Mittal; Goekmen Turan; Amalia A Winters; Timothy D Henry; Hueseyin Ince; Naresh Trehan
Journal:  Stem Cells Transl Med       Date:  2015-07-27       Impact factor: 6.940

Review 10.  Human stem cells for modeling heart disease and for drug discovery.

Authors:  Elena Matsa; Paul W Burridge; Joseph C Wu
Journal:  Sci Transl Med       Date:  2014-06-04       Impact factor: 17.956

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.